New drug shows promise for rare stomach disorder

NCT ID NCT03678545

First seen Nov 05, 2025 · Last updated Apr 24, 2026 · Updated 23 times

Summary

This study tested a drug called dupilumab in 41 people aged 12 to 70 with eosinophilic gastritis, a condition where certain white blood cells build up in the stomach and cause pain and swelling. Participants received injections of dupilumab or a placebo every two weeks for 12 weeks. The main goal was to see if the drug could reduce the number of these cells in the stomach lining.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EOSINOPHILIC GASTROENTERITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • Northwestern Medicine Digestive Health Center

    Chicago, Illinois, 60611, United States

  • Riley Children's Hospital

    Indianapolis, Indiana, 46202, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Tufts Medical Center

    Boston, Massachusetts, 02111, United States

  • University of Colorado Denver and Hospital

    Aurora, Colorado, 80045, United States

  • University of North Carolina School of Medicine

    Chapel Hill, North Carolina, 27599, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Utah Hospital

    Salt Lake City, Utah, 84132, United States

Conditions

Explore the condition pages connected to this study.